P3 Health Partners Stock Today
| PIII Stock | USD 0.17 0.01 6.25% |
PerformanceVery Weak
| Odds Of DistressAbove Average
|
P3 Health is trading at 0.17 as of the 20th of March 2025. This is a 6.25 percent increase since the beginning of the trading day. The stock's open price was 0.16. P3 Health has more than 60 % chance of experiencing financial distress in the next few years of operation. It also generated negative returns for investors over the last 90 days. The performance scores are derived for the period starting the 20th of December 2024 and ending today, the 20th of March 2025. Click here to learn more.
P3 Health Partners Inc., a patient-centered and physician-led population health management company, provides superior care services in the United States. P3 Health operates under Medical Care Facilities classification in the United States and is traded on NASDAQ Exchange. The company has 163.12 M outstanding shares of which 1.91 M shares are at this time shorted by private and institutional investors with about 1.4 trading days to cover. More on P3 Health Partners
Moving together with PIII Stock
Moving against PIII Stock
PIII Stock Highlights
| CEO President | Aric MD |
| Business Concentration | Healthcare, Medical Care Facilities, Health Care, Health Care Equipment & Supplies, Medical Care Facilities, Healthcare (View all Sectors) |
P3 Health Partners (PIII) is traded on NASDAQ Exchange in USA. It is located in 2370 Corporate Circle, Henderson, NV, United States, 89074 and employs 400 people. P3 Health is listed under Healthcare category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 89.42 M. P3 Health Partners conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 163.12 M outstanding shares of which 1.91 M shares are at this time shorted by private and institutional investors with about 1.4 trading days to cover.
P3 Health Partners currently holds about 63.15 M in cash with (76.03 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.52, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check P3 Health Probability Of Bankruptcy
Ownership AllocationP3 Health Partners secures a total of 163.12 Million outstanding shares. P3 Health Partners owns majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 62.07 % of P3 Health Partners outstanding shares that are owned by insiders implies they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company retains, if the real value of the entity is less than the current market value, you may not be able to make money on it.
Check PIII Ownership Details
P3 Health Partners Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. P3 Health market risk premium is the additional return an investor will receive from holding P3 Health long position in a well-diversified portfolio.
| Risk Adjusted Performance | (0.01) | |||
| Jensen Alpha | (0.21) | |||
| Total Risk Alpha | 0.3427 | |||
| Treynor Ratio | 0.119 |
PIII Stock Against Markets
P3 Health Corporate Management
| Timothy Wilson | Senior Management | Profile | |
| Peter Lymm | Market Region | Profile | |
| BSN CRNI | Chief Staff | Profile | |
| Leslie Fisher | General Affairs | Profile | |
| Rebecca Lindy | Executive Economics | Profile | |
| Kassi APR | Culture Communications | Profile |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in P3 Health Partners. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Is Healthcare space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of P3 Health. If investors know PIII will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about P3 Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of P3 Health Partners is measured differently than its book value, which is the value of PIII that is recorded on the company's balance sheet. Investors also form their own opinion of P3 Health's value that differs from its market value or its book value, called intrinsic value, which is P3 Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because P3 Health's market value can be influenced by many factors that don't directly affect P3 Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between P3 Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if P3 Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, P3 Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.